# Study of Rituximab in Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease

> **NCT00472225** · PHASE2 · UNKNOWN · sponsor: **The Korean Society of Hematopoietic Stem Cell Transplantation** · enrollment: 42 (estimated)

## Conditions studied

- Steroid-Refractory Chronic GVHD

## Interventions

- **DRUG:** Rituximab

## Key facts

- **NCT ID:** NCT00472225
- **Lead sponsor:** The Korean Society of Hematopoietic Stem Cell Transplantation
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-05
- **Primary completion:** 2008-05
- **Final completion:** 2009-05
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2009-02-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00472225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00472225, "Study of Rituximab in Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00472225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*